1
Martin James MacPhee, William Nash Drohan, Carlos I Lasa Jr, Gene Liau, Christian Haudenschild: Supplemented and unsupplemented tissue sealants, methods of their production and use. The American National Red Cross, Sterne Kessler Goldstein & Fox P L L C, March 6, 2001: US06197325 (232 worldwide citation)

This invention provides methods for the localized delivery of supplemented tissue sealants, wherein the supplemented tissue sealants comprise at least one composition which is selected from one or more antibodies, analgesics, anticoagulants, anti-inflammatory compounds, antimicrobial compositions, a ...


2
Martin James MacPhee, William Nash Drohan, Gene Liau, Christian Haudenschild: Supplemented and unsupplemented tissue sealants, method of their production and use. The American National Red Cross, Sterne Kessler Goldstein & Fox P L L C, September 12, 2000: US06117425 (128 worldwide citation)

This invention provides supplemented tissue sealants, methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one cytotoxin or cell proliferation inhibiting composition. The composition may be further supplemented with, for example, one or more antibodi ...


3
William N Drohan, Martin J MacPhee, Hernan Nunez, Gene Liau, Thomas Maciag, Wilson H Burgess: Methods for treating wound tissue and forming a supplemented fibrin matrix. The American National Red Cross, Sterne Kessler Goldstein & Fox P L L C, March 27, 2007: US07196054 (28 worldwide citation)

This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one antimicrobial composition. The composition may be further supplemented with, for example, one or more antibodi ...


4
William N Drohan, Martin J MacPhee, Wilson H Burgess, Hernan Nunez, Manish Singh, Gene Liau, Thomas Maciag: Supplemented and unsupplemented tissue sealants, methods of their production and use. The American National Red Cross, Stern Kessler Goldstein & Fox P L L C, March 13, 2007: US07189410 (28 worldwide citation)

This invention provides a fibrin sealant bandage, wherein said fibrin sealant may be supplemented with at least one composition selected from, for example, one or more regulatory compounds, antibody, antimicrobial compositions, analgesics, anticoagulants, antiproliferatives, anti-inflammatory compou ...


5
William N Drohan, Martin J MacPhee, Hernan Nunez, Gene Liau, Wilson H Burgess, Thomas Maciag: Supplemented fibrin matrix delivery systems. The American National Red Cross, Sterne Kessler Goldstein & Fox P L L C, June 12, 2007: US07229959 (22 worldwide citation)

This invention provides supplemented and unsupplemented tissue sealants as well as methods for their production and use thereof. Disclosed are tissue sealants supplemented with at least one antibody. The composition may be further supplemented with, for example, one or more analgesics, antimicrobial ...


6
Gregg A Hastings, Gene Liau, Elena Tsifrina: Hyaluronan-binding proteins and encoding genes. Human Genome Sciences, The American Red Cross, Human Genome Sciences, December 26, 2006: US07153670 (4 worldwide citation)

The present invention relates to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP, members of the hyaluronan receptor family. The invention provides isolated nucleic acid molecules encoding human to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptors. Full-length WF-HABP, WF-HABP, OE-HABP ...


7
Gregg A Hastings, Gene Liau, Elena Tsifrina: Hyaluronan-binding proteins and encoding genes. Human Genome Sciences, The American Red Cross, Human Genome Sciences, March 29, 2005: US06872546 (1 worldwide citation)

The present invention relates to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP, novel members of the hyaluronan receptor family. The invention provides isolated nucleic acid molecules encoding human to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptors. Full-length WF-HABP, WF-HABP, O ...


8
Gene Liau, Steingrimur Stefansson, Joseph Su: Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases. Novartis, J Timothy Meigs, Douglas A Golightly, Geoffrey M Karny, August 26, 2003: US06610534 (1 worldwide citation)

A method of inducing blood vessel formation in an animal by administering to the animal a polynucleotide encoding a sphingosine kinase, or an analogue, fragment, or derivative thereof. The polynucleotide may be contained in an appropriate expression vector, such as a viral vector. The delivery of sp ...


9
Martin J MacPhee, William N Drohan, Gene Liau, Hernan Nunez, Wilson H Burgess, Jeffrey O Hollinger, Thomas Maciag: Supplemented and unsupplemented tissue sealants, methods of their production and use. The American National Red Cross, Sterne Kessler Goldstein & Fox P L L C, October 3, 2006: USRE039321

This invention provides a fibrin sealant dressing, wherein said fibrin sealant may be supplemented with at least one composition selected from, for example, one or more regulatory compounds, antibody, antimicrobial compositions, analgesics, anticoagulants, antiproliferatives, antiinflammatory compou ...


10
Martin J MacPhee, William N Drohan, Gene Liau, Hernan Nunez, Wilson H Burgess, Thomas Maciag, Manish Singh: Supplemented and unsupplemented tissue sealants, methods of their production and use. The American National Red Cross, Sterne Kessler Goldstein & Fox P L L C, September 19, 2006: USRE039298

This invention provides methods for the localized delivery of supplemented tissue sealants, wherein the supplemented tissue sealants comprise at least one composition which is selected from one or more antibodies, analgesics, anticoagulants, anti-inflammatory compounds, antimicrobial compositions, a ...



Click the thumbnails below to visualize the patent trend.